QQ客服 官方微博 反馈留言

浏览/检索结果: 共1条，第1-1条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Compound; composition; method of treating and/or preventing migraine, SRA, Alzheimer' s disease, Parkinson' s disease, disorders EXTRAPIRIMIDAIS, depression, nausea, êmese, restless legs syndrome, insomnia, insult, huntington' s disease, cardiopulmonary disease, fibrogênese, pulmonary hypertension occlusion, anxiety, drug dependence, dystonia, or in a subject PARASSONIAHIPERLACTINEMIA; methods of agoniza??o d2 receptors, 5 it ht1d, 5 it ht1a and 5 it ht2c, in a subject; method of antagonizing d3 receptor in a subject; methods of selective agoniza??o receptors 5 it ht1d, and 5 it ht2c, method of providing functional antagonist activity in the receiver in the receiver or 5 it ht2b 5 it ht7, or both, in a subject; method of providing functional antagonist activity in the receptors in a subject adrenergic 专利 作者:  THOMAS ARMER;  GEOFF MCKINLEY;  SCOTT BORLAND;  MIGUEL GUZMAN;  ARMIN SZABOLCS 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05